Clinical Trials Browser

Phase 2 × Adenocarcinoma Of Esophagus × Aspirin × Clear all

NCT02521285 2025-10-23

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Phase 2 Active not recruiting

21 enrolled 35 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus